PREventing Delayed Graft Function by Driving Immunosuppressive InduCtion Treatment (PREDICT-DGF): study protocol for a randomized controlled trial

BACKGROUND: In kidney transplantation, the use of Anti-Thymocyte Globulins (ATG) as induction therapy has been described as a possible treatment for reducing the prevalence of Delayed Graft Function (DGF). ATG possesses pharmaceutical proprieties that could help control the lesions caused by ischemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapal, Marion, Foucher, Yohann, Marguerite, Monique, Neau, Karine, Papuchon, Emmanuelle, Daguin, Pascal, Morélon, Emmanuel, Mourad, Georges, Cassuto, Elisabeth, Ladrière, Marc, Legendre, Christophe, Giral, Magali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477597/
https://www.ncbi.nlm.nih.gov/pubmed/26099226
http://dx.doi.org/10.1186/s13063-015-0807-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477597/
https://www.ncbi.nlm.nih.gov/pubmed/26099226
http://dx.doi.org/10.1186/s13063-015-0807-x

Ejemplares similares